The Christmas season used to have a couple of great standout events, apart from the Queen’s Speech and the New Year’s Honours List. The other two were Top of the
The Christmas season used to have a couple of great standout events, apart from the Queen’s Speech and the New Year’s Honours List. The other two were Top of the
Shares of clean technology group Verditek (VDTK) bounced back 19%, as some investors took the view that the fall in the stock from 18p plus in the summer down to 8p has
Alan Green talks to John Woolfitt, Director at the multi-award-winning broking and investment firm Atlantic Capital Markets.
Zak Mir highlights some of the most followed stocks on the small-cap London market and gives an overview of the fundamentals in this charting update. Exclusive to Share Talk, here
Zak Mir highlights some of the most followed stocks on the small-cap London market and gives an overview of the fundamentals in this charting update. Exclusive to Share Talk, here
Zak Mir highlights some of the most followed stocks on the small-cap London market and gives an overview of the fundamentals in this charting update. Exclusive to Share Talk, here
Zak Mir highlights some of the most followed stocks on the small-cap London market and gives an overview of the fundamentals in this charting update. Exclusive to Share Talk, here
Zak Mir highlights some of the most followed stocks on the small-cap London market and gives an overview of the fundamentals in this charting update. Exclusive to Share Talk, here
Zak Mir highlights some of the most followed stocks on the small-cap London market and gives an overview of the fundamentals in this charting update. Exclusive to Share Talk, here
Zak Mir highlights some of the most followed stocks on the small-cap London market and gives an overview of the fundamentals in this charting update. Exclusive to Share Talk, here
Zak Mir highlights some of the most followed stocks on the small-cap London market and gives an overview of the fundamentals in this charting update. Exclusive to Share Talk, here are
Graham Mullis, Chief Executive Officer of Novacyt commented. Over the last few days, we have seen significant early demand for our genesig® 2019-nCoV test from over 10 countries.